Fluorecare COMBO 8in1 test | SARS-CoV-2 | Grypa A+B | RSV | RhV | PIV | ADV | hMPV | 1 piece

• sample material: nasal, throat, or nasopharyngeal swab
• painless sample collection
• high product quality
• quick results in just 12 minutes!
• single packaging
• product intended for professional use

Test Specifications

• SARS-CoV-2: specificity: 100%, sensitivity: 92,93%, accuracy: 96,1%
• Influenza A: specificity: 99,55%, sensitivity: 96,82%, accuracy: 98,4%
• Influenza B: specificity: 100%, sensitivity: 97,4%, accuracy: 99%
• RSV: specificity: 100%, sensitivity: 98,72%, accuracy: 99,4%
• RhV: specificity: 98,68%, sensitivity: 97,48%, accuracy: 98,1%
• PIV: specificity: 98,75%, sensitivity: 98,08%, accuracy: 98,4%
• ADV: specificity: 100%, sensitivity: 98,06%, accuracy: 99%
• hMPV: specificity: 100%, sensitivity: 98,04%, accuracy: 99%

The Package Contents

• test cassette
• sample processing solution
• sterile swab
• instruction manual

Test Application 

This test kit is used for the simultaneous qualitative detection and differentiation of novel Coronavirus (SARS-CoV-2) antigen, Influenza A virus, Influenza B virus, RSV antigen, rhinovirus (RhV), parainfluenza virus (PIV), adenovirus (ADV), and human metapneumovirus (hMPV) antigens in population oropharyngeal, nasal, and nasopharyngeal swab samples in vitro. The test is intended for screening purposes, making it ideal for primary care physicians and general practitioners who can quickly confirm or rule out infection with one of the 8 most common respiratory viruses.

Product Identification Data and Responsible Entities

EAN Code: 6971348762537